Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Autor: Mulligan, Nikki, Smith, Elizabeth, Hidalgo-Tenorio, Carmen, Chakhtoura, Nahida, Van Kasteren, Marjo, Fletcher, Courtney C.V., Mirochnick, Mark, Burger, David, Antinori, Andrea, Ende, Ineke van der, Faetkenheuer, Gerd, Schalkwijk, Stein, Giaquinto, Carlo, Gilleece, Yvonne, Gingelmaier, Andrea, Haberl, Annette, Hawkins, David, Ivanovic, Jelena, Kabeya, Kabamba, Lambert, John, Lyons, F., Nellen, Jeannine F J B J., Best, Brookie Manning Dugan B.M., Nicastri, Emanuelle, Rockstroh, Jürgen, Schwarze-Zander, Carolynne, Ruiter, Annemiek de, Sadiq, Tariq, van der Ven, André J A M A.J.A.M., Weizsäcker, Katharina, Wood, Chris G A C., Wyen, Christoph, Colbers, Angela P H, Wang, Jiajia, Capparelli, Edmund E.V., Moltó, José, Stek, Alice A.M., Taylor, Graham G.P.

Publikováno v: Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 7 (2016)
Frontiers in Pharmacology, 7
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Frontiers in pharmacology, vol 7, iss AUG
Frontiers in Pharmacology, 7 (AUG
Mulligan, N; Schalkwijk, S; Best, BM; Colbers, A; Wang, J; Capparelli, EV; et al.(2016). Etravirine pharmacokinetics in HIV-infected pregnant women. Frontiers in Pharmacology, 7(AUG). doi: 10.3389/fphar.2016.00239. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/63b869hf

Background: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women. Methods: IMPAACT P1026s and PANNA are on-going, non-randomized, open-label, parallel-group, multi-center phase-IV prospectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9608e8370fcffabb53639caaf49766
https://doi.org/10.3389/fphar.2016.00239